Arrowhead Pharmaceuticals, Inc.
Alpha-v beta-6 integrin ligands and uses thereof
Last updated:
Abstract:
Integrin ligands having serum stability and affinity for .alpha.v.beta.6 integrins are described. Compositions comprising .alpha.v.beta.6 integrin ligands having serum stability and having affinity for .alpha.v.beta.6 integrins and methods of using them are also described.
Status:
Grant
Type:
Utility
Filling date:
30 Apr 2019
Issue date:
23 Nov 2021